Release Date: 15/12/21 08:26 Summary: Correction to CL1 ASX announcement (Scheme Consideration) Price Sensitive: Yes Download Document 81.82KB Download
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market